United States Medical Imaging Equipment Market to Reach Prominent Value by 2031 | CAGR 5.7% | North America Leads with 38% Share | Key Players: GE Healthcare, Philips, Siemens, Shimadzu, Samsung Medison

Medical Imaging Equipment Market Overview

The Medical Imaging Equipment Market is projected to reach a prominent value by 2031, growing at a CAGR of 5.7% during the forecast period (2024-2031). Medical imaging plays a vital role in modern healthcare by enabling clinicians to visualize the internal structures of the human body to diagnose, monitor, and treat various medical conditions. Techniques such as Magnetic Resonance Imaging (MRI), X-ray, Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET) are commonly used to detect abnormalities, assess organ function, and guide surgical or therapeutic procedures.

These advanced imaging modalities allow radiologists and healthcare professionals to gain precise insights into patient anatomy and physiology without invasive procedures. The growing adoption of AI-enabled imaging systems, increasing prevalence of chronic diseases, rising aging population, and advancements in digital radiography and portable imaging devices are driving the market growth. Furthermore, healthcare digitization and the integration of cloud-based imaging solutions and 3D visualization technologies are revolutionizing diagnostic workflows, enhancing accuracy, and improving patient outcomes.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/medical-imaging-equipment-market?Juli

Recent Developments:

✅ December 2025: Lumexa Imaging made its Nasdaq debut, raising significant capital to expand its diagnostic imaging services network. The company focuses on high-value procedures such as MRI and CT scans, with plans to integrate AI technology to enhance diagnostic accuracy and operational efficiency across its imaging centers.

✅ August 2025: Samsung India, through its subsidiary NeuroLogica, launched a new portfolio of mobile CT systems including CereTom Elite, OmniTom Elite, and BodyTom models. These AI-enabled mobile CT scanners aim to improve access to advanced imaging in critical care and emergency settings, particularly in remote and underserved regions.

✅ November 2025: GE HealthCare announced its acquisition of Intelerad for US$2.3 billion, expanding its footprint into outpatient imaging and cloud-based enterprise imaging software. This strategic move enhances its integrated imaging offerings and accelerates adoption of AI-powered workflows across clinical settings.

✅ 2025: Aidoc received Breakthrough Device Designation from the U.S. FDA for its multi-triage AI solution (CARE1) for CT imaging, enabling simultaneous assessment of multiple acute findings and improving emergency and acute care radiology efficiency.

✅ 2024-2025: GE HealthCare introduced innovations such as the Freelium sealed magnet MRI platform, which uses minimal helium to improve sustainability and accessibility. The company also expanded collaborations to enhance integrated imaging and diagnostic capabilities for improved patient outcomes.

Mergers & Acquisitions:

✅ November 2025: GE HealthCare acquired Intelerad for US$2.3 billion, strengthening its presence in outpatient imaging and cloud-based enterprise imaging solutions. The acquisition aims to enhance AI-enabled workflow integration and improve imaging service delivery across hospitals and diagnostic centers.

✅ October 2025: Philips Healthcare acquired a minority stake in AI imaging startup to accelerate the integration of advanced AI algorithms into its diagnostic imaging platforms, focusing on oncology and cardiovascular imaging.

✅ July 2025: Siemens Healthineers completed the acquisition of a digital pathology and imaging analytics company, enabling the expansion of cloud-based AI diagnostic solutions for hospitals and research institutions.

✅ March 2025: Canon Medical Systems acquired a European imaging software firm, enhancing its portfolio of CT, MRI, and ultrasound software solutions and strengthening its presence in the European healthcare market.

✅ 2024-2025: Several regional diagnostic imaging companies formed strategic partnerships and minority acquisitions with AI-driven imaging startups to accelerate adoption of machine learning and deep learning technologies in radiology workflows.

Key Players:
GE Healthcare | Shimadzu Corporation | Philips Healthcare | Genesis Medical Imaging Inc. | Hologic Inc. | Siemens Healthcare | Samsung Medison Co. Ltd | Carestream Health Inc. | Hitachi Medical Corporation | Fujifilm Holdings Corporation | Toshiba Corporation

Key Highlights:

• GE Healthcare - Holds a 15.0% share, driven by its comprehensive portfolio of MRI, CT, ultrasound, and AI-enabled imaging solutions, along with strong global distribution and service networks.

• Philips Healthcare - Holds a 13.5% share, supported by innovations in diagnostic imaging, interventional systems, and integration of AI in radiology and cardiovascular imaging.

• Siemens Healthcare - Holds a 12.8% share, offering advanced MRI, CT, and hybrid imaging systems, focusing on workflow efficiency, patient comfort, and AI-driven diagnostics.

• Shimadzu Corporation - Holds a 9.5% share, specializing in X-ray, ultrasound, and CT imaging systems, with strong penetration in Asia-Pacific and industrial imaging sectors.

• Samsung Medison Co. Ltd - Holds a 7.8% share, emphasizing ultrasound and portable imaging systems, with AI-enabled diagnostic features for obstetrics, cardiology, and general imaging.

• Hologic Inc. - Holds a 6.2% share, focusing on women's health imaging solutions, including mammography, breast tomosynthesis, and bone densitometry systems.

• Carestream Health Inc. - Holds a 5.5% share, offering digital X-ray, imaging IT, and cloud-based radiology solutions, catering to hospitals and diagnostic centers.

• Fujifilm Holdings Corporation - Holds a 5.0% share, providing multimodal imaging solutions including ultrasound, X-ray, and digital radiography, with a strong emphasis on innovation and AI integration.

• Hitachi Medical Corporation - Holds a 4.8% share, delivering MRI, CT, and ultrasound systems with advanced imaging and ergonomic designs for clinical settings.

• Toshiba Corporation - Holds a 4.7% share, focusing on high-end CT, MRI, and ultrasound equipment with advanced diagnostic capabilities.

• Genesis Medical Imaging Inc. - Holds a 3.0% share, specializing in mobile imaging and service solutions primarily for regional and community healthcare providers.

Buy Now & Unlock 360° Market Intelligence: -https://www.datamintelligence.com/buy-now-page?report=medical-imaging-equipment-market?Juli

Market Segmentation:

➥By Product Type, X-ray systems dominate the market with a 22% share, owing to their widespread use, cost-effectiveness, and versatility in routine diagnostics. Computed Tomography (CT) scanners hold 18%, driven by their high-resolution imaging capabilities for critical care and emergency applications. Magnetic Resonance Imaging (MRI) accounts for 15%, favored for soft tissue imaging and neurological applications. Ultrasound systems contribute 14%, supported by their safety, portability, and extensive use in obstetrics, gynecology, and cardiology. Nuclear imaging systems hold 6%, used in oncology and functional diagnostics. Emerging modalities such as Tactile Imaging, Photoacoustic Imaging, Thermography, Elastography, Echocardiography, Functional Near-Infrared Spectroscopy (fNIRS), and Mammography together account for 25%, with adoption growing due to technological advancements and AI integration.

➥By Application, Oncology leads with a 21% share, reflecting the increasing cancer prevalence and the use of imaging for diagnosis, staging, and treatment monitoring. Cardiology follows with 18%, driven by cardiovascular disease detection and interventional procedures. Neurology represents 14%, benefiting from MRI and CT adoption for brain and nervous system imaging. Gynecology accounts for 12%, largely due to ultrasound and MRI applications. Orthopedics holds 10%, supporting imaging for trauma and musculoskeletal disorders. Gastroenterology contributes 9%, and Other applications such as urology and pulmonology account for the remaining 16%.

➥By End-User, Hospitals and Clinics dominate with a 60% share, being the primary adopters of multimodal imaging systems for in-patient and outpatient diagnostics. Diagnostic Imaging Centers hold 25%, focusing on specialized imaging services and outpatient diagnostics. Ambulatory Surgery Centers (ASCs) account for 15%, leveraging portable and cost-effective imaging equipment for preoperative and intraoperative use.

Regional Insights:

North America dominates the global medical imaging equipment market, accounting for approximately 38% of the total share. The region's leadership is driven by the strong presence of leading technology providers such as GE Healthcare, Philips, Siemens, and Canon, along with early adoption of advanced imaging modalities like AI-enabled MRI, CT, and PET systems. High healthcare spending, a well-established hospital infrastructure, and stringent regulatory frameworks further support market growth in the United States and Canada.

Europe holds a significant 27% share of the market, supported by increasing investments in healthcare infrastructure, digital imaging adoption, and strong government initiatives promoting early disease detection. Countries such as Germany, France, and the UK are major contributors, with growing use of advanced imaging techniques in oncology, cardiology, and neurology.

The Asia-Pacific region is expected to witness the fastest growth, contributing around 24% of the market. Rapid urbanization, expanding healthcare infrastructure, and rising chronic disease prevalence in countries like China, India, Japan, and South Korea are driving demand for cost-effective and portable imaging systems. The adoption of AI-assisted imaging solutions and government initiatives to improve diagnostic access are further boosting growth.

Latin America accounts for roughly 6% of the market, with countries like Brazil and Mexico emerging as key hubs for diagnostic imaging expansion. Growing healthcare awareness, the adoption of digital imaging solutions, and an increasing number of private diagnostic centers are fueling market growth.

The Middle East & Africa (MEA) region holds the remaining 5%, driven by investments in modern healthcare facilities, medical tourism, and adoption of portable and hybrid imaging systems across countries like the UAE, Saudi Arabia, and South Africa.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/medical-imaging-equipment-market?Juli

Market Dynamics:

Drivers:
The growth of the medical imaging equipment market is primarily driven by the rising prevalence of chronic and lifestyle-related diseases, including cancer, cardiovascular, and neurological disorders, which require accurate and early diagnosis. The aging global population further fuels demand for advanced imaging solutions. Technological advancements, such as AI-enabled imaging, 3D/4D imaging, portable devices, and cloud-based imaging solutions, are enhancing diagnostic accuracy, workflow efficiency, and patient outcomes. Additionally, the increasing adoption of minimally invasive procedures has boosted the demand for high-resolution imaging modalities like MRI, CT, and ultrasound.

Restraints:
High costs associated with advanced imaging equipment and maintenance, especially for MRI, CT, and nuclear imaging systems, limit adoption in small clinics and developing regions. The complexity of operation, need for trained personnel, and stringent regulatory approvals for new devices can slow market expansion. Additionally, budget constraints in public healthcare systems and limited awareness in rural areas may restrict widespread adoption.

Opportunities:
There are significant growth opportunities in emerging markets such as Asia-Pacific, Latin America, and the Middle East, where healthcare infrastructure is rapidly improving. Increasing investments in AI and machine learning for automated diagnostics, cloud-based imaging, and integration of multi-modal imaging systems are creating new avenues for market expansion. Innovations in portable, low-cost, and hybrid imaging systems offer opportunities to improve accessibility in remote and underserved regions.

Trends:
Key trends shaping the market include the integration of AI and deep learning algorithms into imaging modalities to assist in early disease detection and predictive diagnostics. There is growing adoption of portable and handheld imaging devices, especially for emergency and point-of-care applications. Sustainability initiatives, such as low-helium MRI systems and energy-efficient imaging equipment, are becoming increasingly important. Collaborations between imaging companies, healthcare providers, and AI startups are driving innovative imaging solutions and enhancing patient-centric care models.

Product Portfolio:

• GE Healthcare offers a comprehensive portfolio of medical imaging equipment designed to address a wide range of diagnostic and interventional needs across healthcare settings. Key products include:

• OEC 3D C-arm - Advanced imaging for orthopedic, surgical, and vascular procedures, offering 3D visualization and real-time imaging guidance.

• Allia IGS 7 - Integrated image-guided surgery system providing precision in minimally invasive interventions.

• LOGIQ E10 Series - High-performance ultrasound systems for general imaging, cardiology, and radiology applications.

• Definium Tempo - Digital X-ray systems designed for high throughput and excellent image quality in hospitals and clinics.

• SIGNA Hero - MRI systems delivering advanced imaging, faster scan times, and enhanced patient comfort.

• AMX Navigate & StarGuide - Surgical navigation and imaging solutions to improve intraoperative accuracy.

• Vscan Air & Vscan Extend - Portable handheld ultrasound devices for point-of-care diagnostics.

• LOGIQ Ultrasound Series, Venue Fit, Venue Go, Venue - Versatile ultrasound systems for multi-specialty use.

• Voluson Signature Series - Specialized ultrasound systems for obstetrics and gynecology imaging.

• Vivid Cardiovascular Ultrasound - Dedicated systems for cardiovascular imaging, including strain imaging and 4D echo.

• Invenia ABUS 2.0 - Automated breast ultrasound for improved detection in dense breast tissue.

• Versana Premier & Versana Active Ultrasound Systems - Affordable and scalable ultrasound solutions for general imaging and point-of-care applications.

The portfolio reflects GE Healthcare's commitment to innovation, offering solutions across MRI, CT, X-ray, ultrasound, and interventional imaging, with a strong focus on AI integration, portability, workflow efficiency, and patient-centered care.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.